The interaction of antibody-antigen complexes with cells results in a wide range of immune responses, including antibody-dependent cellular cytotoxicity, mast cell degranulation, phagocytosis, cell proliferation, antibody secretion and enhancement of antigen presentation [1] [2] [3] . These interactions are initiated through binding of the Fc portions of antibodies or immune complexes to cell surface receptors on hematopoietic cells. For example, IgG antibodies bind the Fcγ receptor on macrophages and neutrophils, mediating phagocytosis of opsonized microorganisms and/or secretion of cytokines involved in inflammation. IgE antibodies induce the release of chemical mediators from mast cells and basophils by binding to the Fcε receptor. Considerable progress has been made in determining the structural and functional diversity of the Fc receptors for IgG and IgE. Results obtained from Fc receptor-deficient mice show important roles for these receptors in host immunity, allergy and autoimmunity [4] [5] [6] [7] [8] [9] [10] . Analysis of mice lacking the gene that encodes the α subunit of the high-affinity IgE receptor, Fcε receptor I, reveals a defect in IgE-triggered passive anaphylaxis due to the absence of the Fcε receptor I on mast cells and basophils 4 . Similarly, mice with a disrupted γ gene encoding IgE Fcε receptor I or IgG Fcγ receptors I and III exhibit identical phenotypes 5 . Knockout mice that lack the gene encoding the Fc receptor γ also lack IgG-mediated phagocytosis by macrophages 5 and the ability to mount the Arthus reaction 6 . In contrast to these triggering Fc receptors, the Fcγ receptor IIb inhibits B cell receptor-triggered lymphocyte proliferation, antibody secretion and lymphokine secretion 1 . Antibody and anaphylactic responses to antigen are increased in mice lacking the gene encoding the Fcγ receptor IIb 7 . IgM is the first antibody to be produced in a humoral immune response and, as such, it may play an important role in the initial stages of immunity. In addition, the natural antibodies involved in preventing pathogen dissemination to vital organs are mainly IgM 11 , although it is not known how IgM protects against infection. The existence of functional Fc receptors for IgM on subpopulations of human and murine T, B and NK cells has been suggested [12] [13] [14] [15] [16] [17] . However, in contrast to Fcγ and Fcε receptors, the structural and functional characteristics of the Fcµ receptor are unclear because a gene encoding the Fcµ receptor has not yet been cloned, although a polymeric immunoglobulin receptor that is able to bind IgM and IgA has been described 18 . Similarly, although a gene encoding human Fcα receptor (also known as CD89) has been characterized 19 , a homologous murine Fcα receptor has not yet been identified. During this investigation we identified a murine Fc receptor, Fcα/µR, and its human homolog that binds both IgA and IgM. We describe the functional and molecular characteristics of this receptor.
Results

Characteristics of Fcα/µR
To identify a Fc receptor for IgM we screened COS-7 cells transfected with a cDNA library prepared from the mouse T cell leukemia cell line, BW5147, using a mouse IgM monoclonal antibody (mAb) as a probe. We isolated a 2361-bp cDNA clone that contained an open reading frame encoding a type I transmembrane protein with a 32-aa leader sequence, a 423-aa extracellular domain, a 20-aa transmembrane domain and a 60-aa cytoplasmic region (Fig. 1a) . The extracellular domain has four potential sites for NH2-linked glycosylation, suggesting that the receptor is a glycoprotein. A pair of cysteine residues in the extracellular domain are flanked by the consensus sequence for nature immunology (Fig. 1a,b) , indicating that this molecule, designated mFcα/µR, is a member of the immunoglobulin supergene family. A human cDNA with homology to mFcα/µR was isolated from a human lymph node cDNA library and was found to encode a protein with 49% amino acid identity to mFcα/µR. These genes were mapped by fluorescence in situ hybridization (FISH) 20 to syntenic regions of mouse chromosome 1 (1F) and human chromosome 1 (1q32.3), near several other Fc receptors including Fcγ receptors I-III, the Fcε receptor and the polymeric immunoglobulin receptor 21 . No tyrosines were present in the cytoplasmic domain, but there is a di-leucine motif in mFcα/µR that may be involved in receptor internalization. Fcα/µR was found to be unique, showing no significant homology to other proteins or nucleotide sequences recorded in the GenBank, EMBL or DDBJ databases. However, we did observe a motif in the immunoglobulin-like domain that is conserved in the first immunoglobulin-like domain of human, bovine and murine polymeric immunoglobulin receptors, and which binds to IgA-Fc and IgMFc [22] [23] [24] (Fig. 1b) . Overall, Fcα/µR has less than 10% amino acid homology with the mouse and human polymeric immunoglobulin receptor.
COS-7 cells were transfected with Flag-tagged mFcα/µR cDNA at the NH2 terminus, which resulted in surface expression of the receptor as detected by immunofluorescence using a mAb to Flag (data not shown). Immunoprecipitation of Flag-tagged mFcα/µR on the COS-7 transfectants using anti-Flag revealed the presence of a ∼70-kD protein under both reducing and nonreducing conditions (Fig. 1c) .
Expression of Fcα/µR
To analyze expression of mFcα/µR in various tissues we used reverse transcription polymerase chain reaction (RT-PCR). mFcα/µR is expressed in several tissues including thymus, spleen, liver, kidney, small and large intestines, testis and placenta (Fig. 2a) . mFcα/µR transcripts were also detected in the T cell leukemia cell lines, RLmale1 and BW5147 (data not shown). To further examine expression of mFcα/µR on hematopoietic cells, RNA was obtained from lymphohematopoietic progenitor and lineage-committed cells in the bone marrow, thymus and spleen. mFcα/µR transcripts were expressed in B220 + B cells in bone marrow and spleen, but not in lymphohematopoietic progenitors, granulocytes, T cells or NK cells (Fig. 2b) . To confirm the cell surface expression of mFcα/µR protein, we generated a mAb (rat IgG isotype) to mFcα/µR. Analysis of spleen cells by flow cytometry showed that Fcα/µR was expressed on the majority of B cells and macrophages but not on granulocytes, T cells or NK cells (Fig. 2c) .
Fcα/µR binds IgM and IgA
To determine the binding specificity of this receptor, we established a Ba/F3 transfectant stably expressing mFcα/µR. Flow cytometric analysis showed that the transfectant specifically bound several mouse IgM mAbs and both dimeric and monomeric IgA mAbs but not any of the IgG mAbs tested including mouse IgG1, IgG2a, IgG2b and IgG3 (Fig.  3a) . The mFcα/µR transfectant also bound rat IgM and IgA mAbs, and human IgM (data not shown). In contrast, the parental Ba/F3 cells, which do not express Fcα/µR, did not bind any of these mAbs ( Fig. 3a) . In addition, the Ba/F3 transfectant bound the Fc, but not F(ab′)2, fragment of human IgM (Fig. 3c) . Therefore, Fcα/µR is a specific Fc receptor for the mouse IgM and IgA and crossreacts with human and rat IgM, and rat IgA.
To confirm the binding specificity the Ba/F3 transfectant was preincubated with pure mouse IgM or rat IgA mAbs and then stained with different FITC-conjugated mouse or rat IgM mAbs. Binding of FITC-labeled mouse IgM and IgA mAbs was inhibited by preincubation of the transfectant with IgM or IgA mAbs (Fig. 3b) , indicating that the molecule is a specific receptor for IgM and IgA. Binding of IgM and IgA to mFcα/µR expressed on the Ba/F3 transfectant was also determined with 125 I-labeled ligands. mFcα/µR bound with high affinity any species of IgM tested. In addition, mFcα/µR bound mouse IgA with intermediate affinity (Fig. 3d) . 
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Endocytosis of IgM-coated bead
The cytoplasmic domain of mFcα/µR contains a di-leucine motif (Fig.  1a) , implicated in endosome and lysosome targeting of diverse proteins and involved in agonist-induced internalization [25] [26] [27] [28] . A di-leucine motif is involved in Fcγ receptor IIB-mediated endocytosis 3, 29 . To investigate whether Fcα/µR internalizes on cross-linking, the Ba/F3 transfectants expressing Fcα/µR were incubated with FITC-labeled mouse IgM and then cross-linked with goat anti-mouse IgM at 4 o C or 37 o C for 1 h. Some of the transfectants were treated with trypsin to remove the FITC-labeled mouse IgM bound to the cell surface Fcα/µR that had not been internalized. For the transfectant that expressed Fcα/µR, and which was incubated at 4 o C after cross-linking, treatment with trypsin significantly decreased the fluorescence intensity (Fig. 4a) . In contrast, fluorescence remained constant in the transfectant which was incubated at 37 o C after cross-linking, despite treatment with trypsin. This suggested that cross-linking Fcα/µR with IgM induced internalization of Fcα/µR during culture at 37 o C. We next examined whether Fcα/µR was involved in endocytosis. Ba/F3 transfectants expressing mFcα/µR were incubated with IgM-coated fluorescent beads at 37 o C. After extensive washing and treatment with trypsin, we analyzed the cells by flow cytometry and a subpopulation of the Ba/F3 transfectants containing fluorescent beads was detected (Fig. 4b) . Using immunofluorescent microscopy and confocal scanning laser microscopy, the fluorescent beads were also seen in the cytoplasm of the transfectants (Fig. 4c-e) indicating that Fcα/µR was involved in endocytosis of IgM-coated beads. Transfectants incubated with fluorescent beads that were not coated with IgM were not engulfed by the transfectants (data not shown).
Fcα/µ receptor di-leucine motif
We examined next whether the di-leucine motif at residues 519 and 520 in the cytoplasmic portion of mFcα/µR was involved in the internalization of Fcα/µR. We made Ba/F3 transfectants that stably expressed Fcα/µR molecules that were mutated at residue 519, 520, or both and incubated them with IgM-coated green fluorescent beads at 37 o C. The fluorescent beads were not detected in any of the Ba/F3 transfectants that expressed mutant Fcα/µR (Fig. 4b) . These results indicated that both the residue 519 and 520 leucines are required for internalization [30] [31] [32] [33] using a mechanism that is dependent on the associated subunit Fc receptor γ chain 34 . However, we did not observe an association between the Fcα/µ receptor with the γ chain. Because the human Fcα/µR does not have a di-leucine motif in its cytoplasmic domain, other elements in the human receptor probably serve this function instead.
Endocytosis by primary B lymphocytes
To examine the biological significance of Fcα/µR-mediated endocytosis, mouse spleen cells were incubated with immune complexes composed of FITC-labeled S. aureus bacteria coated with IgM or IgG antibodies to S. aureus. After overnight culture, the cells were treated with trypsin, stained with phycoerythrin (PE)-anti-B220 and analyzed by flow cytometry. Although B220 + spleen cells cultured with the IgG S. aureus immune complex did not show any specific green fluorescence, a subset of B220 + cells cultured with the S. Aureus IgM immune complex showed detectable fluorescence. When spleen cells were precoated with rat anti-mFcα/µR and incubated with the IgM-S. aureus complex, B220
+ cells did not show any specific fluorescence (Fig. 4f) . The B220 + B cells incubated with the IgM-S. aureus complexes were isolated by flow cytometry, examined by fluorescence microscopy, and were found to contain one or more FITC-labeled S. aureus bacteria in their cytoplasm (Fig. 4g,h) . These results indicated that mFcα/µR mediates endocytosis of IgM-coated microbial pathogens.
Discussion
Previous reports suggested the existence of functional Fc receptors for IgM on murine and human T, B and NK cells [12] [13] [14] [15] [16] [17] . However, the functional and molecular characteristics of these Fcµ receptors have remained elusive. Among them is a human Fcµ receptor, a ∼60 kD glycosyl phosphatidylinositol (GPI)-linked protein, that is expressed on activated B cells but not on macrophages 15 . The Fcα/µR we describe here is ∼70 kD transmembrane-type glycoprotein expressed on both B cells and macrophages, which suggests that these Fc receptors are different. The localization of the Fcα/µR gene on chromosome 1 suggested that Fcα/µR may be evolutionary related to the Fcγ receptors, the Fcε receptor and the polymeric immunoglobulin receptor, but distinct from the human Fcα receptor whose gene is mapped to chromosome 19 21 . We have shown that Fcα/µR is expressed not only on hematopoietic cells but also on variable nonhematopoietic organs including liver, kidney, small and large intestines, testis and placenta. Although the polymeric immunoglobulin receptor, which also binds IgM and IgA, is expressed on epithelial cells, it is unclear whether Fcα/µR is expressed on epithelial cells or on infiltrated hematopoietic cells in these organs. Similarly, although purified thymic T lymphocytes do not express Fcα/µR, thymic tissue does.
We have also demonstrated functional expression of Fcα/µR on B lymphocytes. Transfection of Ba/F3 cells with Fcα/µR enabled these pro-B cells to engulf IgM-coated particles. In addition, we demonstrated primary B lymphocyte uptake of IgM-coated microbial pathogens such as S. aureus, through the Fcα/µR, showing the physiological relevance of this receptor. These results suggested at least two types of Fcα/µR-mediated immune response. Fcα/µR may be involved in the protection of bacterial infections by allowing phagocytosis of IgM-coated organisms and by facilitating subsequent antigen processing and presentation to helper T lymphocytes. Reports have demonstrated that mice deficient in the secretory form of IgM exhibit delayed development of specific IgG antibodies to T cell-dependent foreign antigens 35 and dissemination of micropathogens in peripheral organs but not secondary lymphoid organs 11 . These reports suggest that uptake, through Fcα/µR, of IgMantigen immune complexes by B lymphocytes and macrophages may play an essential role in the priming of helper T lymphocytes. Analysis of mice lacking the gene that encodes Fcα/µR will help determine the physiological role of this receptor.
Methods
Antibodies. For binding assays, monoclonal antibodies to human CD18 (L130, mouse IgG1), CD3 (UCTH1, mouse IgG1), CD45 (H130, mouse IgG1), CD71 (M-A712, mouse IgG2a), CD11c (LeuM5, mouse IgG2b), CD2 (Leu5b, mouse IgG2b), CD52 (DX8, mouse IgG3) and CD57 (Leu7, mouse IgM), and monoclonal antibodies to DX18 (mouse IgM), M18-254 (mouse IgA), DX5 (rat IgM), TX2 (rat IgM), TX1 (rat IgA) as well as human IgM (obtained from a patient with macroglobulinemia, a gift from T. Azuma, Science University, Tokyo), and human IgM-Fc (Rockland, Gilbertsville, PA) were used. Monoclonal antibodies to human CD3, CD45 and CD71, and M18-254 were purchased from PharMingen (San Diego, CA). Monoclonal antibodies to DX5, DX8, DX18, TX1 and TX2 were generated in our laboratories. For flow cytometric analysis and sorting of the spleen, bone marrow and thymus, control IgG, anti-mouse TCRαβ, anti-mouse CD45R (or B220) and anti-mouse CD11b (Mac1), anti-mouse Sca-1, anti-mouse c-kit, anti-Ly6G (Gr-1), TER119, anti-mouse CD90 (Thy-1), anti-NK1.1, anti-mouse CD4 and anti-mouse CD8 were used (PharMingen). An anti-mouse Fcα/µR (TX6) was generated by fusing the Sp2/0 myeloma cell line with splenocytes from a rat immunized with Ba/F3 transfectants expressing mouse Fcα/µR 36 .
Reverse transcription--polymerase chain reaction (RT-PCR).
RNA was subjected to reverse transcription and PCR using Fcα/µR-specific primers (5′-AGTGTTACCAC-GAGTGAAGG-3′ and 5′-TTCCATCATCAGGGTCTTGG-3′) or glyceraldehyde phosphodehydrogenase (GAPDH)-specific primers (5′-TGCACCACCAACTGCTTAG-3′ and 5′-GGATGCAGGGATGATGTTC-3′). Using an ABI7700 analytical thermal cycler (Perkin-Elmer Applied Biosystem, Foster City, CA), cDNA was measured and TaqMan rodent GAPDH control reagent (Perkin-Elmer Applied Biosystem) was used to standardize results. PCR was done at 40 cycles of 20 s denaturation (at 94 o C), 20 s annealing (at 55 o C), and 20 s extension (at 72 o C).
Establishment of Ba/F3 transfectants. Fcα/µR cDNA was subcloned into the pMX-NEO retroviral vector (provided by T. Kitamura, DNAX) using the EcoRI (5′) and NotI (3′) cloning sites. To generate site-directed mFcα/µR mutants at residues Leu 519 and/or Leu 520 , PCR primers that contained a codon for Ala 519 (GCT) and/or Ala 520 (GCT) instead of Leu 519 (CTT) and Leu 520 (CTT), respectively, were designed. The PCR products were subcloned into the pMX-NEO vector. All mutant cDNAs were verified by sequencing. Ba/F3 cells stably expressing wild-type or mutant Fcα/µR were established 37 .
Scatchard analysis. Antibodies were labeled by chloramine-T-catalyzed iodination and purified by gel-filtration chromatography on a PD-10 column (Sephadex G-25 M, Pharmacia Biotech, Uppsala). Binding of Ba/F3 transfectants with 125 I-labeled antibodies and scatchard analysis were done 17 .
Internalization assay. Ba/F3 cells expressing Fcα/µR were stained with FITC-labeled mouse IgM (DX18 mAb), followed by cross-linking with goat anti-mouse IgM (PharMingen) at 4 o C or 37 o C for 1 h. Some cells were treated with 0.1% trypsin and analyzed by flow cytometry. For internalization of IgM-coated beads, Ba/F3 cells expressing the wild-type or mutant Fcα/µR were incubated at 37 o C for overnight with yellow-green fluorescent beads (FluoSpheres Fluorescent Microspheres, 0.5 µm sized in diameter, Molecular Probes, Eugene, OR), which had been conjugated with mouse IgM (DX18 mAb) as per manufacturers instructors. The cells were then washed with PBS and treated with 0.1% trypsin to remove beads bound to the cell surface. The cells were centrifuged onto microscope slides, rapidly air-dried, and then analyzed using fluorescent and confocal scanning laser microscopes. To analyze endocytosis of the immune complexes, green fluorescent S. aureus (Molecular Probes) were incubated with either medium alone, anti-S. aureus mouse IgM or anti-S. aureus mouse IgG (QED Bioscience Inc., San Diego, CA). S. aureus was then incubated overnight with spleen cells from C57Bl/6 mice pretreated with anti-mouse FcγRIII/II (PharMingen) to block interaction with Fcγ receptors. In some experiments, the anti-Fcα/µR (TX6) was also used to block interaction with the Fcα/µ receptor. The spleen cells were then treated with 0.1% trypsin, stained with PE-anti-B220 and analyzed by flow cytometry. B220 + B lymphocytes expressing green fluorescence were sorted, cytospinned onto slides and analyzed by using a fluorescent microscope. 
